What CSR means for the world of health: An overview of CSR practices in the pharmaceutical industry

Abstract : This article proposes a new Corporate Social Responsibility (CSR) framework allowing the evaluation of responsible behaviors and practices in a specific industry. Considering the CSR as a negotiated order in ongoing construction, the partnership between the private and public parties can become a solution in the general interest. The implementation of these partnerships along the value chain enables CSR to be placed as a business opportunity that could develop the strategic potential of the company. The evaluation framework provides an objective view. We are going to mobilize this through an exploratory study filled with qualitative data obtained through websites and CSR reports from 2013 of the ten biggest multinational pharmaceutical industries, proving the know-how of this sector in the field of industrial durability.
Type de document :
Communication dans un congrès
4th International Conference on Social Responsibility, Ethics and Sustainable Business, Oct 2015, athens, Greece
Liste complète des métadonnées

https://hal-univ-lyon3.archives-ouvertes.fr/hal-01217939
Contributeur : Nathalie Gimenes <>
Soumis le : mardi 20 octobre 2015 - 13:27:51
Dernière modification le : mercredi 21 octobre 2015 - 01:04:21

Identifiants

  • HAL Id : hal-01217939, version 1

Collections

Citation

Nathalie Gimenes, Marielle Audrey Payaud. What CSR means for the world of health: An overview of CSR practices in the pharmaceutical industry. 4th International Conference on Social Responsibility, Ethics and Sustainable Business, Oct 2015, athens, Greece. 〈hal-01217939〉

Partager

Métriques

Consultations de la notice

82